- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01252966
Cognitive Training for Nicotine Dependence
12 januari 2017 uppdaterad av: University of Pennsylvania
This randomized clinical trial tested the effects of a computerized (web-based) cognitive training intervention on smoking cessation.
All participants received 8 weeks of standard nicotine patch therapy, smoking cessation counseling, and were randomized to 1 of 2 different training programs: cognitive training vs. control training.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
213
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, Förenta staterna, 19104
- Center for Interdiscplinary Research on Nicotine Addiction, University of Pennsylvania
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år till 65 år (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion:
- Healthy male and female treatment-seeking smokers who are between 18 and 65 years of age and self-report smoking at least 5 cigarettes (menthol and/or non-menthol) per day for at least the last 6 months
- Plan to live in the area for at least the next 8 months
- Capable of giving written informed consent, which includes compliance with the requirements and restrictions listed in the combined consent and HIPAA form
- Able to communicate fluently in English (speaking, writing, and reading)
- Have uninterrupted access to a home computer with sound capabilities, keyboard, mouse, and active Internet connection
- Provide a Carbon Monoxide (CO) breath test reading greater than or equal to 8 parts per million (ppm) at Intake Visit
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Cognitive Training
Participants in this arm received computerized cognitive training in addition to nicotine patch and smoking cessation counseling.
|
The computerized cognitive training intervention is a 12-week standardized course of internet-based computerized cognitive exercises designed to enhance executive cognitive function.
|
|
Placebo-jämförare: Control Training
Participants in this arm received computerized control training in addition to nicotine patch and smoking cessation counseling
|
The computerized control training intervention is a 12-week standardized course of internet-based deep breathing exercises which does not contain the cognitive exercises designed to enhance executive cognitive function.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Point-prevalence Abstinence at End of Treatment
Tidsram: End of treatment (Week 12)
|
Daily smoking, from the Target Quit Date to End of Treatment (EOT), was assessed by a validated timeline follow-back measure.
Based on guidelines for smoking cessation trials, the primary outcome was 7-day point prevalence abstinence at EOT, and abstinence was defined as no self-reported smoking (even a puff) for at least 7 days, with in-person verification by carbon monoxide breath levels (CO <8ppm).
Following standard convention, participants who withdrew or were lost to follow-up were considered smokers.
|
End of treatment (Week 12)
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Point-prevalence Abstinence at 6-month Follow-up
Tidsram: 6 month follow-up
|
Daily smoking from the Target Quit Date to 6 month follow-up was assessed by a validated timeline follow-back measure.
Based on guidelines for smoking cessation trials, the secondary outcome was 7-day point prevalence abstinence at the 6 month follow-up, and abstinence was defined as no self-reported smoking (even a puff) for at least 7 days, with in-person verification by carbon monoxide breath levels (CO <8ppm).
Following standard convention, participants who withdrew or were lost to follow-up were considered smokers.
|
6 month follow-up
|
|
Cognitive Performance (Working Memory)
Tidsram: Baseline and Week 12 (EOT)
|
Change in performance on the Digit Span Forward task (working memory) between Baseline and End of Treatment (Week 12).
In this task, participants are presented with a series of digits on the computer screen at one second intervals.
Participants are then required to enter the digits in order.
The number of digits in each series ranges from 3 to 7, and the maximum recall span is the length of the largest series entered correctly.
The outcome measure is the change score (calculated by subtracting the Baseline score from the end of treatment score).
Change scores can range from -4 to 4. Negative numbers indicate worse performance at EOT; positive numbers indicate better performance at EOT; and 0 indicates no change.
|
Baseline and Week 12 (EOT)
|
|
Cognitive Performance (Response Inhibition)
Tidsram: Baseline and Week 12 (EOT)
|
Change in performance on the Go/No-Go Task (response inhibition) between Baseline and End of Treatment (Week 12).
In this task, participants are presented with a series of stimuli (the word "PRESS" in either green or red).
Participants are instructed to respond by pressing the spacebar when the stimulus is green, and to withhold a response when the stimulus is red.
The outcome is the change in number of commission errors (failure to withhold a response to a red stimulus) from EOT minus baseline.
The potential range for the change score is -42 to 42.
Negative numbers indicate a decrease in the number of commission errors (improved performance) from baseline to EOT; positive numbers indicate an increase in commission errors (worse performance); 0 indicates no change.
|
Baseline and Week 12 (EOT)
|
|
Cognitive Performance (Attention)
Tidsram: Baseline and Week 12 (EOT)
|
Change in performance on the Continuous Performance Task (attention) between Baseline and End of Treatment (Week 12).
In this task, participants are presented with a series of letters at 2.5s intervals and are instructed to respond by pressing the space bar if the same letter appears twice in a row.
The outcome is the change in the number of commission errors (the number of times the participant responded to a non-target at EOT minus baseline).
There are a total of 125 trials, with 20 target trials (response required) and 85 non-target trials (no response required); therefore the possible range for the change score is -85 to 85. Negative numbers indicate a decrease in commission errors (better performance at EOT compared to baseline); positive numbers indicate an increase in commission errors (worse performance at EOT compared to baseline); and 0 indicates no change.
|
Baseline and Week 12 (EOT)
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Utredare
- Huvudutredare: Caryn Lerman, PhD, University of Pennsylvania
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 mars 2011
Primärt slutförande (Faktisk)
1 september 2015
Avslutad studie (Faktisk)
1 september 2015
Studieregistreringsdatum
Först inskickad
1 december 2010
Först inskickad som uppfyllde QC-kriterierna
1 december 2010
Första postat (Uppskatta)
3 december 2010
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
16 januari 2017
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
12 januari 2017
Senast verifierad
1 januari 2017
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 812429
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .